CompletedNot Applicable

Biomarkers in Pediatric Inflammatory Rheumatic Diseases

Spain20 participantsStarted 2018-09-05

Plain-language summary

A prospective study is proposed to serially determine new biomarkers: Calprotectin and Serum Amyloid Protein, alongside 'conventional' biomarkers: CRP and ESR, to help evaluate their utility in routine clinical practice

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients in follow-up in our Pediatric Rheumatology Unit, with the diagnoses of: Juvenile Idiopathic Arthritis, Connective Diseases or Autoinflammatory Diseases Exclusion Criteria: No

What they're measuring

Serum Calprotectin in pediatric population with rheumatological inflammatory diseases

Timeframe: Months 3, 6, 9 and 12

Trial details

NCT IDNCT07356804

SponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12-30

View on ClinicalTrials.gov More Juvenile Idiopathic Arthritis trials